English

Biohit clarifies the impact of the Luminex agreement on the company's result

Report this content 
BIOHIT OYJ        STOCK EXCHANGE RELEASE              28 SEP 2005


Biohit clarifies the impact of the Luminex agreement on the
company’s result

Biohit expects that the cooperation with the US-based company
Luminex will increase sales of Biohit’s diagnostic products in
2006. The company estimates that the revenue and profitability of
its diagnostics business in 2006 will increase by more than 10%
compared to the figures in 2005. Biohit announced the cooperation
agreement with Luminex in the stock exchange release published on
27 September 2005.

Biohit Oyj
Osmo Suovaniemi
President & CEO

Further information:   Osmo Suovaniemi, M.D., Ph.D.,
                       Professor
                       President & CEO
                       Tel: +358-9-773 861
                       Mobile: +358-40-745 5605
                       Email: osmo.suovaniemi@biohit.com
                       
                       http://www.biohit.com
                       
Distribution:          Helsinki Exchanges
                       Financial Supervisory Authority
                       Press

Subscribe